Cephei Capital Management (Hong Kong) Ltd — Inside Their 13F Portfolio
Cephei Capital Management (Hong Kong) Ltd
CIK: 0001843237
Long-term holder
Total reported value
—
Reporting period: 2023-09-30 · Number of holdings: 1
Cephei Capital Management (Hong Kong) Ltd disclosed 1 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Position changes disclosed by Cephei Capital Management (Hong Kong) Ltd for the quarter ending 2023-09-30, including ticker, issuer, weight change, shares change, and action
What is Cephei Capital Management (Hong Kong) Ltd and what type of investor is it?
Cephei Capital Management (Hong Kong) Ltd is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Cephei Capital Management (Hong Kong) Ltd's largest equity positions?
Based on the latest 13F filing, Cephei Capital Management (Hong Kong) Ltd's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Cephei Capital Management (Hong Kong) Ltd make in its most recent portfolio filing?
No notable portfolio changes were recorded for Cephei Capital Management (Hong Kong) Ltd in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Cephei Capital Management (Hong Kong) Ltd focus on?
Sector breakdown data is not yet available for Cephei Capital Management (Hong Kong) Ltd. Check back after the next 13F processing cycle.